<DOC>
	<DOCNO>NCT00148642</DOCNO>
	<brief_summary>The purpose study determine use silver-coated endotracheal tube ( ETT ) reduce incidence and/or delay time onset VAP compare non silver-coated ETT patient mechanically ventilate &gt; = 24 hour .</brief_summary>
	<brief_title>Silver-Coated Endotracheal Tube Reduce Ventilator Associated Pneumonia ( VAP )</brief_title>
	<detailed_description>Nosocomial pneumonia lead cause death hospital-acquired infections.Ventilator associate pneumonia ( VAP ) develop significant percentage patient ventilate least 48 hour , associate high morbidity , mortality , financial cost . Silver well-characterized antimicrobial agent , active agent multiple medical product use reduce control infection . Bard develop proprietary antimicrobial ETT , manufacture hydrophilic coat contain fine dispersion silver salt . This study compare incidence time onset VAP patient intubate &gt; =24 hour proprietary silver-coated ETT versus intubate &gt; = 24 hour standard non-coated ETT .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<criteria>age &gt; 18 year expect intubate least 24 hour able sign Informed Consent symptom bronchiectasis severe hemoptysis history cystic fibrosis intubate &gt; 12 hour within previous 30 day pregnancy participate compete trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>ventilator-associated pneumonia</keyword>
	<keyword>nosocomial pneumonia</keyword>
</DOC>